Abeona Therapeutics Inc. (ABEO)

2.97
NASDAQ : Health Technology
Prev Close 3.14
Day Low/High 2.95 / 3.20
52 Wk Low/High 1.46 / 14.70
Avg Volume 1.17M
Exchange NASDAQ
Shares Outstanding 49.32M
Market Cap 154.85M
EPS -1.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Abeona Therapeutics Announces Positive Interim Data From The ABO-102 Phase 1/2 Gene Therapy Clinical Trial In MPS IIIA

Abeona Therapeutics Announces Positive Interim Data From The ABO-102 Phase 1/2 Gene Therapy Clinical Trial In MPS IIIA

Neurocognitive development of youngest patients preserved 12-18 months post treatment; development scores remain within range of unaffected children Robust and sustained biomarker improvement across all dose cohorts with 8 months to 2 years of follow up...

ABEO: Insiders Vs. Shorts

ABEO: Insiders Vs. Shorts

The most recent short interest data was recently released for the 04/15/2019 settlement date, and Abeona Therapeutics Inc is one of the most shorted stocks of the Russell 3000, based on 24.63 "days to cover" versus the median component at 5.30. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

RSI Alert: Abeona Therapeutics (ABEO) Now Oversold

RSI Alert: Abeona Therapeutics (ABEO) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week Of August 16th Options Trading For Abeona Therapeutics (ABEO)

First Week Of August 16th Options Trading For Abeona Therapeutics (ABEO)

Investors in Abeona Therapeutics Inc saw new options begin trading this week, for the August 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ABEO options chain for the new August 16th contracts and identified the following call contract of particular interest.

First Week Of July 19th Options Trading For Abeona Therapeutics (ABEO)

First Week Of July 19th Options Trading For Abeona Therapeutics (ABEO)

Investors in Abeona Therapeutics Inc saw new options become available this week, for the July 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ABEO options chain for the new July 19th contracts and identified one put and one call contract of particular interest.

Abeona Therapeutics Becomes Oversold (ABEO)

Abeona Therapeutics Becomes Oversold (ABEO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

These 2 Biotech Stocks Are No Longer 'Off the Radar'

These 2 Biotech Stocks Are No Longer 'Off the Radar'

Few parts of the market have more volatility than the small caps in this sector.

ABEO: Insiders Vs. Shorts

ABEO: Insiders Vs. Shorts

The most recent short interest data was recently released for the 03/29/2019 settlement date, and Abeona Therapeutics Inc is one of the most shorted stocks of the Russell 3000, based on 22.30 "days to cover" versus the median component at 4.78. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Interesting ABEO Put And Call Options For February 15th

Interesting ABEO Put And Call Options For February 15th

Investors in Abeona Therapeutics Inc saw new options begin trading this week, for the February 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ABEO options chain for the new February 15th contracts and identified one put and one call contract of particular interest.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: OFS, REX Downgrades: ABEO, ELON, SAFM, TRC Initiations: NCSM Read on to get TheStreet Quant Ratings' detailed report:

First Week Of ABEO August 17th Options Trading

First Week Of ABEO August 17th Options Trading

Investors in Abeona Therapeutics Inc saw new options become available this week, for the August 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ABEO options chain for the new August 17th contracts and identified one put and one call contract of particular interest.

Newman Ferrara LLP Announces Corporate Governance Investigation Of Abeona Therapeutics Inc. - ABEO

Newman Ferrara LLP Announces Corporate Governance Investigation Of Abeona Therapeutics Inc. - ABEO

Newman Ferrara LLP announced today that the firm is conducting an investigation on behalf of stockholders of Abeona Therapeutics Inc.

First Week Of July 20th Options Trading For Abeona Therapeutics (ABEO)

First Week Of July 20th Options Trading For Abeona Therapeutics (ABEO)

Investors in Abeona Therapeutics Inc saw new options become available this week, for the July 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ABEO options chain for the new July 20th contracts and identified one put and one call contract of particular interest.

Abeona Therapeutics Breaks Below 200-Day Moving Average - Notable For ABEO

Abeona Therapeutics Breaks Below 200-Day Moving Average - Notable For ABEO

In trading on Monday, shares of Abeona Therapeutics Inc crossed below their 200 day moving average of $15.80, changing hands as low as $15.55 per share. Abeona Therapeutics Inc shares are currently trading down about 9.6% on the day.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ABEO, AXP, NNN, SSI, WMK, WUBA Downgrades: AXTI, CGA, RWC Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

15 Biotech Firms That Have Strong Potential to Be Acquired: Jefferies

15 Biotech Firms That Have Strong Potential to Be Acquired: Jefferies

'Balance sheets are flush with cash and there is a need to grow for large health care companies,' Jefferies analysts wrote.

Abeona Therapeutics Reports Fourth Quarter 2017 Financial Results And Business Highlights

Abeona Therapeutics Reports Fourth Quarter 2017 Financial Results And Business Highlights

Investor Conference Call on Tuesday, March 27th at 10:00 am ET

Abeona Therapeutics Receives FDA Rare Pediatric Disease Designation For ABO-202 Gene Therapy Program In CLN1 Disease

Abeona Therapeutics Receives FDA Rare Pediatric Disease Designation For ABO-202 Gene Therapy Program In CLN1 Disease

Company's 4th Gene Therapy Program to Receive Rare Pediatric Disease Designation, enabling Priority Review Voucher

Traders Need to Adapt to a New Reality

Traders Need to Adapt to a New Reality

The volatility trade that propped up markets is no longer available.

Noteworthy Wednesday Option Activity: ABEO, RRTS, OFG

Noteworthy Wednesday Option Activity: ABEO, RRTS, OFG

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Abeona Therapeutics Inc , where a total volume of 5,894 contracts has been traded thus far today, a contract volume which is representative of approximately 589,400 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 74.6% of ABEO's average daily trading volume over the past month, of 790,020 shares.

Short Interest In Abeona Therapeutics Expands By 17.8%

Short Interest In Abeona Therapeutics Expands By 17.8%

The most recent short interest data has been released for the 12/29/2017 settlement date, which shows a 1,252,929 share increase in total short interest for Abeona Therapeutics Inc , to 8,311,831, an increase of 17.75% since 12/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

TheStreet Quant Rating: D (Sell)